News
India says Goodbye to Maternal and Neonatal Tetanus
India eliminated Maternal and Neonatal Tetanus (MNT) addressed Prime Minster Narendra Modi in a Call to Action Submit, 2015. Representatives of 24 nations attended the conference and the Prime Minister of India, said “I am happy to share with you today another major milestone achieved by India. India has eliminated
An End to Repeat Animal Testing
South East Asian countries including India, Philippines, Thailand, Malaysia, Singapore, Indonesia, Vietnam are currently in the process of developing standards for the regulatory approval processes for medical devices, drugs and cosmetics. The Indian medical device and drugs regulatory approval body has made a decision to stop repeat animal testing to
How Much Can an Accounting Error Cost?
To correct the incorrect financial statements, an Austin based medical device manufacturer estimates the cost as $28 million. In the third party accounting costs the company incurred $ 16 million in the recent SEC filing and it will spend another $12 million to correct the quarterly statements for the years
CDSCO to Maintain Inventory for Veterinary Medicines
There has been a standard regulation in practice for the medicines used for human but there are no strict measures for the usage of veterinary medicines. READ ALSO: Standard regulation of medical devices in India, Achievements of the CDSCO (Regulatory Body of India) 2014. As a result, the veterinarians says there is misuse
Seperate Regulation for Medical Devices in India
A bill which is awaited to be passed in the parliament of India which would enable distinguish medical devices and drugs regulations in India. An association of medical device manufacturer, AdvaMed said there are around 14000 types of medical devices and only 22 are listed as notified medical devices in
How Many Sub-Standard Drugs in India?
The Central government of India informed the result of drug testing which they conducted in the last three years. 4.4% of drugs were found to be of substandard in India: 9092 were found to be of substandard quality out of 2,05,448 samples tested collected from 36 states. In a written reply
A New Regulatory Body for AYUSH Drugs
Lok Shabha informed, “A structured regulatory regime for AYUSH drugs is considered to be set up”. Shripad Naik, the minister of AYUSH said in written to parliament of India, “Government mulls a structured regulatory regime for AYUSH (Ayurveda, Siddha, Unani and Homoeopathy) drugs. The proposal is to have a vertical
India to Put Mechanism on Online Sale of Drugs
A subcommittee which would draft a mechanism to sale prescription drugs online says studying other countries online drug sales should also be involved in the part of the regulations for the same. The committee was formed by the Drugs Controller General of India (DCGI). Dr Harshdeep Kamble, Maharashtra Food &
Indian Regulatory Structure: What you need to know?
The Indian government’s intention for many years to oversee registration of medical devices in India with a developed regulatory structure which is still not materialized but there were a number of steps taken to move the medical device registration to a substantial one. To look after the growing medical device
Another Hope For Indian Medical Device Industry Growth
By 2016, the Indian medical device industry is expected to grow from $ 4.4 billion to $ 7 billion addressed by a US – India business body in a government meeting. The US – India business school (USIBC) also stressed the importance of separate regulations for medical devices. READ ALSO: